THCH
TH International Limited
THCH offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
TSLA
Tesla, Inc.
TSLA has the edge over THCH overall, supported by stronger fundamentals and lower modeled downside.
THCH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
THCH's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
THCH PE Valuation
THCH has no meaningful PE right now: it lost money over the past year.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
THCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect THCH's earnings, revenue and profitability to hold roughly steady.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
TSLA has the edge over THCH on the outlook, with more favorable earnings and revenue expectations.
THCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.33 | -$0.70 |
| Q1 2026 | -$2.23 | -$0.73 |
| Q4 2025 | -$1.99 | -$0.08 |
| Q3 2025 | -$1.56 | +$1.19 |
| Q2 2025 | -$1.63 | +$1.47 |
| Q1 2025 | -$1.50 | +$2.51 |
| Q4 2024 | -$1.91 | +$2.62 |
| Q3 2024 | -$2.75 | +$2.00 |
THCH is still losing money, but far less than before: $2.33 per share over the past year, against $5.40 at its worst in mid-2023.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA has the edge over THCH on earnings quality, reporting a profit while its opponent remains loss making.
THCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.9M | -22% |
| Q1 2026 | $38.3M | -15% |
| Q4 2025 | $45.7M | -8.5% |
| Q3 2025 | $53.7M | -0.4% |
| Q2 2025 | $52.4M | -4.9% |
| Q1 2025 | $45.1M | -9.5% |
| Q4 2024 | $49.9M | -15% |
| Q3 2024 | $54M | -17% |
THCH's revenue has slid since its 2023 peak: $41M last quarter, down 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -20% | -9.2 points |
| Q1 2026 | -26% | -2.2 points |
| Q4 2025 | -28% | +2.1 points |
| Q3 2025 | -15% | -4.6 points |
| Q2 2025 | -11% | +4 points |
| Q1 2025 | -24% | +13 points |
| Q4 2024 | -30% | +29 points |
| Q3 2024 | -11% | +23 points |
THCH's operating margin was −20% last quarter, down 9.2 points from the same quarter a year ago.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA has the edge over THCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA has the edge over THCH on profitability, with a higher operating margin.
THCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5.1M | +$5.3M |
| Q1 2026 | -$3.5M | -$3.5M |
| Q4 2025 | -$11.3M | -$6.5M |
| Q3 2025 | -$257.1K | +$1.7M |
| Q2 2025 | -$176.3K | -104% |
| Q1 2025 | -$32.9K | +$4M |
| Q4 2024 | -$4.7M | +$51.2M |
| Q3 2024 | -$2M | +$2.6M |
THCH has burned cash in almost every quarter: −$10M over the past year, against −$7M the year before.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA has the edge over THCH on cash generation, producing positive trailing cash flow while its opponent burns cash.
THCH Net Leverage
THCH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has more cash than debt.
THCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 33.1 | Neutral |
THCH's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
THCH PE vs Consumer Cyclical Sector
THCH has no meaningful PE right now: it lost money over the past year.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
THCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.17 | 6% above |
| 20 week MA | $1.40 | 11% below |
| 50 week MA | $1.79 | 31% below |
| 100 week MA | $2.32 | 47% below |
| 200 week MA | $6.07 | 80% below |
THCH has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 80% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over THCH on trend strength, trading above more of its moving averages.
THCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $49.1 | $48.9 | -0.4% |
| 2022 | $48.9 | $15.7 | -68% |
| 2023 | $15.7 | $8.75 | -44% |
| 2024 | $8.75 | $3.73 | -57% |
| 2025 | $3.73 | $2.19 | -41% |
| 2026 YTD | $2.19 | $1.24 | -43% |
THCH has finished every year since 2021 lower, and it's down 43% so far in 2026.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA has the edge over THCH on returns for 2026, with the stronger performance.